🎉 M&A multiples are live!
Check it out!

Accuray Valuation Multiples

Discover revenue and EBITDA valuation multiples for Accuray and similar public comparables like Myomo, InfuSystem, and SmartVest.

Accuray Overview

About Accuray

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.


Founded

1990

HQ

United States of America
Employees

987

Website

accuray.com

Financials

LTM Revenue $464M

LTM EBITDA $27.3M

EV

$306M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Accuray Financials

Accuray has a last 12-month revenue of $464M and a last 12-month EBITDA of $27.3M.

In the most recent fiscal year, Accuray achieved revenue of $447M and an EBITDA of $5.7M.

Accuray expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Accuray valuation multiples based on analyst estimates

Accuray P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $448M $447M XXX XXX XXX
Gross Profit $160M $154M XXX XXX XXX
Gross Margin 36% 34% XXX XXX XXX
EBITDA $8.4M $5.7M XXX XXX XXX
EBITDA Margin 2% 1% XXX XXX XXX
Net Profit -$5.3M -$9.3M XXX XXX XXX
Net Margin -1% -2% XXX XXX XXX
Net Debt $91.7M $87.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Accuray Stock Performance

As of April 15, 2025, Accuray's stock price is $2.

Accuray has current market cap of $155M, and EV of $306M.

See Accuray trading valuation data

Accuray Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$306M $155M XXX XXX XXX XXX $-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Accuray Valuation Multiples

As of April 15, 2025, Accuray has market cap of $155M and EV of $306M.

Accuray's trades at 0.7x LTM EV/Revenue multiple, and 11.2x LTM EBITDA.

Analysts estimate Accuray's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Accuray and 10K+ public comps

Accuray Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $306M XXX XXX XXX
EV/Revenue 0.7x XXX XXX XXX
EV/EBITDA 17.5x XXX XXX XXX
P/E -19.1x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Accuray Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Accuray Valuation Multiples

Accuray's NTM/LTM revenue growth is 5%

Accuray's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Accuray's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Accuray's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Accuray and other 10K+ public comps

Accuray Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 4% XXX XXX XXX XXX
EBITDA Growth -32% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 9% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 10% XXX XXX XXX XXX
G&A Expenses to Revenue 11% XXX XXX XXX XXX
R&D Expenses to Revenue 11% XXX XXX XXX XXX
Opex to Revenue 32% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Accuray Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Accuray M&A and Investment Activity

Accuray acquired  XXX companies to date.

Last acquisition by Accuray was  XXXXXXXX, XXXXX XXXXX XXXXXX . Accuray acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Accuray

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Accuray

When was Accuray founded? Accuray was founded in 1990.
Where is Accuray headquartered? Accuray is headquartered in United States of America.
How many employees does Accuray have? As of today, Accuray has 987 employees.
Who is the CEO of Accuray? Accuray's CEO is Ms. Suzanne C. Winter.
Is Accuray publicy listed? Yes, Accuray is a public company listed on NAS.
What is the stock symbol of Accuray? Accuray trades under ARAY ticker.
When did Accuray go public? Accuray went public in 2007.
Who are competitors of Accuray? Similar companies to Accuray include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Accuray? Accuray's current market cap is $155M
What is the current revenue of Accuray? Accuray's last 12-month revenue is $464M.
What is the current EBITDA of Accuray? Accuray's last 12-month EBITDA is $27.3M.
What is the current EV/Revenue multiple of Accuray? Current revenue multiple of Accuray is 0.7x.
What is the current EV/EBITDA multiple of Accuray? Current EBITDA multiple of Accuray is 11.2x.
What is the current revenue growth of Accuray? Accuray revenue growth between 2023 and 2024 was 0%.
Is Accuray profitable? Yes, Accuray is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.